Hi William,
Webinar: The REPROCELL Tissue Network: Facilitating Dermatology Drug Development
In North America: Wednesdday, 28 September 2020 at 12:00 PM EDT / 9:00 AM PDT. Register here
In Europe: Wednesday, 28 September 2020 at 12:00 PM GMT/ 1:00 PM CET. Register here
Fresh human tissue-based assays offer researchers the ability to combine drug efficacy and safety testing in a highly complex human system that accurately reflects human tissue and disease biology.
While these types of assays have long been considered a gold-standard approach for the prediction of clinical efficacy and safety, their widespread adoption has been hampered by concerns surrounding tissue availability, reproducibility and the logistics of handling these fresh viable tissues.
During this webinar, we will discuss the challenges, technical considerations and benefits of working with fresh human tissue in research. A particular focus will be on the access and use of fresh human skin biopsies to model human skin diseases such as psoriasis and atopic dermatitis for drug efficacy testing.
About the Speakers
Dr. Graeme Macluskie is the Head of Research and Development at REPROCELL Europe. Dr. Macluskie has more than 15 years of experience in designing and delivering preclinical projects for companies in Pharmaceutical nd Biotech. He joined REPROCELL in 2011, where he currently leads a team that develops a range of tissue-based assays, including inflammation models of IBD, psoriasis, and COPD.
Dr. Karen McAulay is the Clinical Alliances Manager for REPROCELL Europe. After earning her degree from the University of Glasgow, she received her Ph.D. in Biomedical Sciences from the University of Edinburgh, studying the immune response to EBV infection. After a stint as a Research Fellow at the University of Glasgow studying the risk factors for EBV disease, she joined REPROCELL in 2017, where manages the regulatory, growth and maintenance aspects of the REPROCELL Global Tissue and Clinical Alliance network for Predictive Drug Discovery Services.
Sincerely,